96 related articles for article (PubMed ID: 3263712)
1. Circulating osteocalcin during oral anticoagulant therapy.
van Haarlem LJ; Knapen MH; Hamulyák K; Vermeer C
Thromb Haemost; 1988 Aug; 60(1):79-82. PubMed ID: 3263712
[TBL] [Abstract][Full Text] [Related]
2. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
van Leeuwen Y; Rosendaal FR; van der Meer FJ
Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro.
Barone LM; Aronow MA; Tassinari MS; Conlon D; Canalis E; Stein GS; Lian JB
J Cell Physiol; 1994 Aug; 160(2):255-64. PubMed ID: 8040186
[TBL] [Abstract][Full Text] [Related]
4. The in vivo effects of oral anticoagulants in man: comparison between liver and non-hepatic tissues.
de Boer-van den Berg M; Thijssen HH; Vermeer C
Thromb Haemost; 1988 Apr; 59(2):147-50. PubMed ID: 3260413
[TBL] [Abstract][Full Text] [Related]
5. Influence of anticoagulants on growth and vitamin K production of intestinal bacteria.
Johanni M; Ungerechts J; Werner H; Leistner E
Pharmazie; 1991 Aug; 46(8):595-6. PubMed ID: 1798715
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K: the coagulation vitamin that became omnipotent.
Cranenburg EC; Schurgers LJ; Vermeer C
Thromb Haemost; 2007 Jul; 98(1):120-5. PubMed ID: 17598002
[TBL] [Abstract][Full Text] [Related]
7. Statin use decreases coagulation in users of vitamin K antagonists.
van Rein N; Biedermann JS; Bonafacio SM; Kruip MJ; van der Meer FJ; Lijfering WM
Eur J Clin Pharmacol; 2016 Dec; 72(12):1441-1447. PubMed ID: 27709253
[TBL] [Abstract][Full Text] [Related]
8. Decreased serum osteocalcin levels in phenprocoumon-treated patients.
Pietschmann P; Woloszczuk W; Panzer S; Kyrle P; Smolen J
J Clin Endocrinol Metab; 1988 May; 66(5):1071-4. PubMed ID: 3258869
[TBL] [Abstract][Full Text] [Related]
9. Invasive procedures in the outpatient setting: managing the short-acting acenocoumarol and the long-acting phenprocoumon.
van Geest-Daalderop JH; Hutten BA; Péquériaux NC; de Vries-Goldschmeding HJ; Räkers E; Levi M
Thromb Haemost; 2007 Oct; 98(4):747-55. PubMed ID: 17938797
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K and bone health in adult humans.
Bügel S
Vitam Horm; 2008; 78():393-416. PubMed ID: 18374202
[TBL] [Abstract][Full Text] [Related]
11. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K and oral anticoagulation: thought for food.
Bovill EG; Fung M; Cushman M
Am J Med; 2004 May; 116(10):711-3. PubMed ID: 15121498
[No Abstract] [Full Text] [Related]
13. The effect of vitamin K supplementation on anticoagulant treatment.
Rombouts EK; Rosendaal FR; van der Meer FJ
J Thromb Haemost; 2006 Mar; 4(3):691-2. PubMed ID: 16460460
[No Abstract] [Full Text] [Related]
14. Vitamin K and bone health.
Bügel S
Proc Nutr Soc; 2003 Nov; 62(4):839-43. PubMed ID: 15018483
[TBL] [Abstract][Full Text] [Related]
15. Does vitamin K excess induce ectopic calcifications in hemodialysis patients?
Robert D; Jorgetti V; Leclercq M; Lacour B; Ulmann A; Bourdeau A; Drüeke T
Clin Nephrol; 1985 Dec; 24(6):300-4. PubMed ID: 3878250
[TBL] [Abstract][Full Text] [Related]
16. [Modifications in the urinary excretion of gamma-carboxyglutamic acid induced by vitamin K].
Werlen D; Robert D; Leclerq M; Guelpa G; Pfister CE
Schweiz Med Wochenschr; 1988 Feb; 118(6):203-5. PubMed ID: 3259010
[TBL] [Abstract][Full Text] [Related]
17. Skeletal effects of oral anticoagulants.
Francucci CM; Ceccoli L; Rilli S; Fiscaletti P; Caudarella R; Boscaro M
J Endocrinol Invest; 2009; 32(4 Suppl):27-31. PubMed ID: 19724163
[TBL] [Abstract][Full Text] [Related]
18. Osteocalcin. Biochemical considerations and clinical applications.
Lian JB; Gundberg CM
Clin Orthop Relat Res; 1988 Jan; (226):267-91. PubMed ID: 3275514
[TBL] [Abstract][Full Text] [Related]
19. [Changes in blood concentrations of bone-specific biomarkers, osteocalcin and C-telopeptide, in third or higher parity sows after administration of calcium and vitamin D].
Counotte GH; Groenland G; Salden N
Tijdschr Diergeneeskd; 2009 Mar; 134(6):230-7. PubMed ID: 19353919
[TBL] [Abstract][Full Text] [Related]
20. [Vitamin K: biochemistry, function, and deficiency. Review].
Mijares ME; Nagy E; Guerrero B; Arocha-Piñango CL
Invest Clin; 1998 Sep; 39(3):213-29. PubMed ID: 9780555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
